Analyst Price Targets — KIDS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 10, 2025 11:29 am | — | Canaccord Genuity | $24.00 | $18.34 | TheFly | Canaccord starts OrthoPediatrics with a Buy after guidance reset |
| October 29, 2025 9:48 am | Mike Matson | Needham | $26.00 | $16.91 | StreetInsider | OrthoPediatrics Corp. (KIDS) PT Lowered to $26 at Needham |
| October 10, 2025 12:49 pm | Richard Newitter | Truist Financial | $18.00 | $15.60 | TheFly | OrthoPediatrics price target lowered to $18 from $22 at Truist |
| October 10, 2025 12:48 pm | — | Lake Street | $34.00 | $15.55 | TheFly | OrthoPediatrics price target lowered to $34 from $37 at Lake Street |
| October 10, 2025 11:05 am | — | BTIG | $23.00 | $17.95 | TheFly | OrthoPediatrics price target lowered to $23 from $39 at BTIG |
| October 10, 2025 10:56 am | David Turkaly | JMP Securities | $25.00 | $17.95 | TheFly | OrthoPediatrics price target lowered to $25 from $35 at Citizens JMP |
| October 10, 2025 10:54 am | Rick Wise | Stifel Nicolaus | $20.00 | $17.95 | TheFly | OrthoPediatrics price target lowered to $20 from $32 at Stifel |
| October 10, 2025 10:40 am | Matt O'Brien | Piper Sandler | $22.00 | $17.95 | TheFly | OrthoPediatrics price target lowered to $22 from $30 at Piper Sandler |
| August 8, 2025 8:22 am | David Turkaly | JMP Securities | $35.00 | $19.20 | StreetInsider | OrthoPediatrics Corp. (KIDS) PT Lowered to $35 at Citizens JMP |
| March 5, 2025 11:50 am | — | Stifel Nicolaus | $32.00 | $25.61 | TheFly | OrthoPediatrics price target lowered to $32 from $40 at Stifel |
Latest News for KIDS
OrthoPediatrics (KIDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The average of price targets set by Wall Street analysts indicates a potential upside of 32.7% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
WARSAW, Ind., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences.
OrthoPediatrics Corp. (KIDS) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for OrthoPediatrics (KIDS) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for KIDS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.